MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 38 filers reported holding MILESTONE PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 2.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85,523 | +19.2% | 27,588 | +9.6% | 0.00% | 0.0% |
| Q2 2023 | $71,752 | -27.7% | 25,176 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $99,193 | -0.5% | 25,176 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $99,697 | -93.2% | 25,176 | -84.1% | 0.00% | -94.6% |
| Q3 2022 | $1,459,000 | +48.4% | 158,752 | -0.7% | 0.04% | +48.0% |
| Q2 2022 | $983,000 | -16.9% | 159,801 | -13.2% | 0.02% | -10.7% |
| Q1 2022 | $1,183,000 | +3.5% | 184,198 | +5.6% | 0.03% | +3.7% |
| Q4 2021 | $1,143,000 | +14.8% | 174,463 | 0.0% | 0.03% | -3.6% |
| Q3 2021 | $996,000 | -19.4% | 174,463 | -22.4% | 0.03% | -30.0% |
| Q2 2021 | $1,236,000 | +2.5% | 224,758 | +7.9% | 0.04% | -11.1% |
| Q1 2021 | $1,206,000 | -13.6% | 208,332 | 0.0% | 0.04% | -13.5% |
| Q4 2020 | $1,396,000 | -4.1% | 208,332 | +4.8% | 0.05% | -40.9% |
| Q3 2020 | $1,455,000 | +703.9% | 198,708 | +315.7% | 0.09% | +633.3% |
| Q2 2020 | $181,000 | – | 47,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 2,530,585 | $16,955,000 | 0.73% |
| Ikarian Capital, LLC | 1,836,545 | $12,305,000 | 0.54% |
| Boxer Capital, LLC | 2,477,194 | $16,597,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,315,102 | $28,911,000 | 0.48% |
| RA Capital Management | 2,327,714 | $15,596,000 | 0.22% |
| Orbimed Advisors | 2,493,109 | $16,704,000 | 0.15% |
| PURA VIDA INVESTMENTS, LLC | 450,000 | $3,015,000 | 0.11% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 851,291 | $5,704,000 | 0.08% |
| Anson Funds Management LP | 50,113 | $336,000 | 0.07% |
| Tekla Capital Management LLC | 253,610 | $1,699,000 | 0.06% |